US2020061034A1PendingUtilityA1

Buccal, polar and non-polar spray containing zolipidem

Assignee: MAGNA PHARMACEUTICALS INCPriority: Aug 29, 2002Filed: Oct 28, 2019Published: Feb 27, 2020
Est. expiryAug 29, 2022(expired)· nominal 20-yr term from priority
A61P 25/20A61K 9/12A61K 9/006A61K 31/437A61K 9/0056A61K 31/4745A61K 9/4866Y10S514/923A61K 9/28
69
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Buccal aerosol sprays or capsules using polar and non-polar solvents have now been developed which provide zolpidem for rapid absorption through the oral mucosa, resulting in fast onset of effect. The buccal polar compositions of the invention comprise formulation I: aqueous polar solvent, zolpidem, and optional flavoring agent; formulation II: aqueous polar solvent, zolpidem, optionally flavoring agent, and propellant; formulation III: non-polar solvent, zolpidem, and optional flavoring agent; formulation IV: non-polar solvent, zolpidem, optional flavoring agent, and propellant; formulation V: a mixture of a polar solvent and a non-polar solvent, zolpidem, and optional flavoring agent; formulation VI: a mixture of a polar solvent and a non-polar solvent, zolpidem, optional flavoring agent, and propellant.

Claims

exact text as granted — not AI-modified
1 - 62 . (canceled) 
     
     
         63 . A pump spray container comprising:
 an oral spray composition and a metered valve suitable for releasing from said container a predetermined amount of said composition,   wherein the composition is propellant free, and wherein the composition comprises an aqueous polar solvent present at about 30% to about 99.69% by weight of the total composition, zolpidem tartrate at about 0.001% to about 60% by weight of the total composition, and a flavoring agent at about 0.1% to about 10% by weight of the total composition.   
     
     
         64 . The pump spray container of  claim 63 , wherein the composition coats the mucosal membrane with fine droplets of spray. 
     
     
         65 . The pump spray container of  claim 64 , wherein the zolpidem tartrate is rapidly absorbed through the oral mucosa. 
     
     
         66 . The pump spray container of  claim 63 , wherein the zolpidem tartrate is present at about 0.01% to about 20%. 
     
     
         67 . The pump spray container of  claim 63 , wherein the zolpidem tartrate is present at about 0.2% to about 10%. 
     
     
         68 . The pump spray container of  claim 63 , wherein the zolpidem tartrate is present at about 4% to about 5%. 
     
     
         69 . The pump spray container of  claim 63 , wherein the aqueous polar solvent is present at about 30% to about 70%. 
     
     
         70 . The pump spray container of  claim 63 , wherein the aqueous polar solvent is present at about 30% to about 60%. 
     
     
         71 . The pump spray container of  claim 63 , wherein the aqueous polar solvent is present at about 30% to about 40%. 
     
     
         72 . The pump spray container of  claim 63 , wherein the flavoring agent is present at about 0.1% to about 5%. 
     
     
         73 . The pump spray container of  claim 63 , wherein the flavoring agent is present at 0.1% to about 2.5%. 
     
     
         74 . The pump spray container of  claim 63 , wherein the flavoring agent is present at 0.1% to about 0.3%. 
     
     
         75 . The pump spray container of  claim 63 , wherein the flavoring agent is selected from the group consisting of synthetic or natural oil of peppermint, oil of spearmint, citrus oil, fruit flavors, sweeteners, and combinations thereof.

Join the waitlist — get patent alerts

Track US2020061034A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.